C921 | ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´[CML], BCR/ABL-¾ç¼º | Chronic myeloid leukemia[CML],BCR/ABL-positive |
|
C921 | ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´, Çʶóµ¨ÇÇ¾Æ ¿°»öü ¾ç¼º | Chronic myelogenous leukemia, Philadelphia chromosome (Ph1) positive |
|
C921 | ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´, t(9:22)(q34:q11) | Chronic myelogenous leukemia, t(9:22)(q34:q11) |
|
C921 | ¸ð¼¼Æ÷ÀÇ ¹ßÁõÀ» µ¿¹ÝÇÑ ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´ | Chronic myelogenous leukemia with crisis of blast cells |
|
C922 | ºñÁ¤ÇüÀû ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´[CML], BCR/ABL À½¼º | Atypical chronic myeloid leukemia[CML], BCR/ABL-negative |
|
C923 | °ñ¼ö¼º À°Á¾ | Myeloid sarcoma |
|
C923 | ³ì»öÁ¾ | Chloroma |
|
C923 | °ú¸³±¸¼º À°Á¾ | Granulocytic sarcoma |
|
C924 | ±Þ¼º Àü°ñ¼ö±¸¼º ¹éÇ÷º´[PML] | Acute promyelocytic leukemia[PML] |
|
C924 | ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ M3 | AML M3 |
|
C924 | t(15:17) ¹× º¯ÇüÀ» µ¿¹ÝÇÑ ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´Me | AML Me with t(15:17) and variants |
|
C925 | ±Þ¼º °ñ¼ö´ÜÇÙ±¸¼º ¹éÇ÷º´ | Acute myelomonocytic leukemia |
|
C925 | ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ M4 | AML M4 |
|
C925 | inv(16) ¶Ç´Â t(16:16)À» µ¿¹ÝÇÑ ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ M4 Eo | AML M4 Eo with(16) or t(16::16) |
|
C926 | 11q23 ÀÌ»óÀ» µ¿¹ÝÇÑ ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ | Acute myeloid leukaemia with 11q23-abnormality |
|
C926 | MLL-À¯ÀüÀÚ º¯À̸¦ µ¿¹ÝÇÑ ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ | Acute myeloid lrukaemia with variation of MLL-gene |
|
C927 | ±âŸ °ñ¼ö¼º ¹éÇ÷º´ | Other myeloid leukemia |
|
C928 | ´Ù¼¼Æ÷°è Çü¼ºÀÌ»óÀ» µ¿¹ÝÇÑ ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ | Acute myeloid leukaemia with multi-lineage dysplasia |
|
C929 | »ó¼¼ºÒ¸íÀÇ °ñ¼ö¼º ¹éÇ÷º´ | Myeloid leukemia, unspecified |
|
C93 | ´ÜÇÙ±¸¼º ¹éÇ÷º´ | Monocytic leukemia |
|